Skip to main content

Table 6 Associations of continuous and dichotomous mtDNA 8-OHdG with 1-year outcomes after coronary revascularization

From: Mitochondrial 8-hydroxy-2′-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus

Outcomes

Continuous mtDNA 8-OHdG

Dichotomous mtDNA 8-OHdG

HR (95%CI)a

Pa

No. of eventsb

HR (95%CI)a

Pa

High (n = 344)

Low (n = 357)

MACCE

1.59 (1.33–1.90)

< 0.001

78 (22.7)

31 (8.7)

2.74 (1.80–4.17)

< 0.001

All-cause death

2.06 (1.59–2.66)

< 0.001

34 (9.9)

11 (3.1)

3.36 (1.69–6.69)

< 0.001

Cardiac death

1.92 (1.33–2.78)

< 0.001

19 (5.5)

5 (1.4)

3.80 (1.40–10.3)

0.009

Repeat revascularization

1.26 (0.98–1.62)

0.078

47 (13.7)

19 (5.3)

2.67 (1.55–4.57)

< 0.001

Non-fatal MI

1.42 (0.91–2.22)

0.126

12 (3.5)

7 (2.0)

2.30 (0.89–5.92)

0.085

Non-fatal stroke

1.45 (0.59–3.58)

0.417

3 (0.9)

2 (0.6)

1.71 (0.27–10.8)

0.569

  1. MACCE major adverse cardiovascular and cerebral events, MI myocardial infarction
  2. aModels were adjusted for age, sex, smoking habit, alcohol drinking habit, overweight/obesity, hypertension, dyslipidemia., FPG, HbA1c, diabetes duration, and type of diabetes management
  3. bThe cutoff that categorized the value of mtDNA 8-OHdG as high or low was 3.22 ∆ct based on the results of time-dependent ROC